Pantalone KM - Search Results

1

Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.

Pantalone KM, Wells BJ, Chagin KM, Ejzykowicz F, Yu C, Milinovich A, Bauman JM, Kattan MW, Rajpathak S, Zimmerman RS. Pantalone KM, et al. Diabetes Care. 2016 Sep;39(9):1527-34. doi: 10.2337/dc16-0227. Epub 2016 Aug 12. Diabetes Care. 2016. PMID: 27519447

2

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Pantalone KM, et al. Acta Diabetol. 2009 Jun;46(2):145-54. doi: 10.1007/s00592-008-0090-3. Epub 2009 Feb 5. Acta Diabetol. 2009. PMID: 19194648

3

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Pantalone KM, et al. Diabetes Care. 2010 Jun;33(6):1224-9. doi: 10.2337/dc10-0017. Epub 2010 Mar 9. Diabetes Care. 2010. PMID: 20215447 Free PMC article.

4

The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Nutter B, Jain A, Atreja A, Zimmerman RS. Pantalone KM, et al. Diabet Med. 2012 Aug;29(8):1029-35. doi: 10.1111/j.1464-5491.2012.03577.x. Diabet Med. 2012. PMID: 22248043

5

Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Pantalone KM, et al. Diabetes Obes Metab. 2012 Sep;14(9):803-9. doi: 10.1111/j.1463-1326.2012.01604.x. Epub 2012 Apr 29. Diabetes Obes Metab. 2012. PMID: 22486923

6

Liraglutide effective in the severely insulin-resistant patient with type 2 diabetes requiring U-500 insulin: a case report.

Pantalone KM, Faiman C. Pantalone KM, et al. Diabetes Technol Ther. 2013 Apr;15(4):342-3. doi: 10.1089/dia.2012.0328. Epub 2013 Feb 4. Diabetes Technol Ther. 2013. PMID: 23379638

7

Diabetes management: More than just cardiovascular risk?

Zimmerman RS, Pantalone KM. Zimmerman RS, et al. Among authors: pantalone km. Cleve Clin J Med. 2014 Nov;81(11):672-6. doi: 10.3949/ccjm.81a.14033. Cleve Clin J Med. 2014. PMID: 25368217 Free article. No abstract available.

8

Does mortality risk vary among sulfonylureas?

Pantalone KM. Pantalone KM. Lancet Diabetes Endocrinol. 2015 Jan;3(1):6-7. doi: 10.1016/S2213-8587(14)70217-7. Epub 2014 Oct 22. Lancet Diabetes Endocrinol. 2015. PMID: 25466240 No abstract available.

9

Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.

Kannan S, Pantalone KM, Matsuda S, Wells BJ, Karafa M, Zimmerman RS. Kannan S, et al. Among authors: pantalone km. J Diabetes. 2016 Mar;8(2):279-85. doi: 10.1111/1753-0407.12301. Epub 2015 Jun 29. J Diabetes. 2016. PMID: 25929426

10

In Reply: Diabetes therapy and cardiac risk.

Zimmerman RS, Pantalone KM. Zimmerman RS, et al. Among authors: pantalone km. Cleve Clin J Med. 2015 Mar;82(3):140-1. doi: 10.3949/ccjm.82c.03002. Cleve Clin J Med. 2015. PMID: 25932735 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page